On Friday, August 9th, 2024, the highly anticipated Life Sciences Patent Network (LSPN) Fall conference will commence in San Francisco’s Embarcadero district. With the ever-evolving landscape of life science innovation, the protection of intellectual property has become a critical pathway to maximizing impact and return on investment. This conference will bring together the brightest minds in the industry to discuss strategies for bulletproofing patents at every stage of the life cycle.
The LSPN conference, taking place on October 15th and 16th at the Hyatt Regency San Francisco, will provide a unique opportunity for industry leaders to come together and address current challenges and solutions. The recently updated agenda highlights the topics that will be discussed during the event, including real case studies from some of the most innovative and largest companies in the industry.
Attendees will have the chance to hear from industry thought leaders who will share strategies and tactics for staying ahead of competitors. Chairperson Eldora Ellison, Director at Sterne Kessler, explains why she returns to LSPN year after year, stating, “The LSPN conference provides a unique opportunity to gain in-depth knowledge on the cutting-edge issues that are most relevant to my practice. LSPN gives attendees a deep dive into the patent law issues that impact practitioners in the life sciences, both in the US and globally. Additionally, LSPN offers an unparalleled opportunity to network with colleagues and engage in small-group dialogues during roundtable discussions.”
Attendees can expect to:
– Engage in discussions on the latest innovations in protecting intellectual property with speakers from top companies such as Pfizer, Bristol Myers Squibb, BioMarin, 10x Genomics, City of Hope, and Illumina during keynote presentations and panel discussions.
– Hear from industry leaders including Randy Wu, Vice President of Intellectual Property and Litigation at 10x Genomics, Betsy Haane, Senior Vice President of Intellectual Property at IGM Biosciences, and Anand Viswanathan, Director of Intellectual Property at BioMarin Pharmaceuticals.
– Dive into pressing issues related to AI, effective prosecution and enforcement strategies, and multi-jurisdiction challenges with thought leaders and experts during roundtable discussions.
And much more.
For more information and to register, visit the event website. The LSPN Fall conference promises to be the must-attend event for pharma and biotech patent owners this year. We look forward to welcoming attendees and fostering discussions and strategies that will shape the future of life science innovation.
Hannah Gore, Senior Conference Producer at World IP Review, states, “We are excited to bring together industry leaders and experts at this year’s LSPN Fall conference. With a focus on protecting intellectual property, this event will provide attendees with valuable insights, strategies, and networking opportunities. We look forward to seeing the impact these discussions will have on the industry.”
Derick is an experienced reporter having held multiple senior roles for large publishers across Europe. Specialist subjects include small business and financial emerging markets.